Prolonged Fatigue and Mental Health Challenges in Critical COVID-19 Survivors
(2024) In Journal of Intensive Care Medicine- Abstract
Background: The aim of this study was to investigate the development of fatigue and mental illness between 3 and 12 months after critical COVID-19 and explore risk factors for long-lasting symptoms. Study Design and Methods: A prospective, multicenter COVID-19 study in southern Sweden, including adult patients (≥18 years) with rtPCR-confirmed COVID-19 requiring intensive care. Survivors were invited to a follow-up at 3 and 12 months, where patient-reported symptoms were assessed using the Modified Fatigue Impact Scale (MFIS), the Hospital Anxiety and Depression Scale (HADS) and the Posttraumatic Stress Disorder Checklist version 5 (PCL-5). The development between 3 and 12 months was described by changes in relation to statistical... (More)
Background: The aim of this study was to investigate the development of fatigue and mental illness between 3 and 12 months after critical COVID-19 and explore risk factors for long-lasting symptoms. Study Design and Methods: A prospective, multicenter COVID-19 study in southern Sweden, including adult patients (≥18 years) with rtPCR-confirmed COVID-19 requiring intensive care. Survivors were invited to a follow-up at 3 and 12 months, where patient-reported symptoms were assessed using the Modified Fatigue Impact Scale (MFIS), the Hospital Anxiety and Depression Scale (HADS) and the Posttraumatic Stress Disorder Checklist version 5 (PCL-5). The development between 3 and 12 months was described by changes in relation to statistical significance and suggested values for a minimally important difference (MID). Potential risk factors for long-lasting symptoms were analyzed by multivariable logistic regression. Results: At the 3-month follow-up, 262 survivors (87%) participated, 215 (72%) returned at 12 months. Fatigue was reported by 50% versus 40%, with a significant improvement at 12 months (MFIS; median 38 vs. 33, P < .001, MID ≥4). There were no significant differences in symptoms of mental illness between 3 and 12 months, with anxiety present in 33% versus 28%, depression in 30% versus 22%, and posttraumatic stress disorder in 17% versus 13%. A worse functional outcome and less sleep compared to before COVID-19 were risk factors for fatigue and mental illness at 12 months. Conclusions: Fatigue improved between 3 and 12 months but was still common. Symptoms of mental illness remained unchanged with anxiety being the most reported. A worse functional outcome and less sleep compared to before COVID-19 were identified as risk factors for reporting long-lasting symptoms.
(Less)
- author
- organization
-
- Anesthesiology and Intensive Care
- Brain Injury After Cardiac Arrest (research group)
- Clinical Research in Anaesthesia and Intensive Care Medicine (research group)
- Unit for clinical suicide research (research group)
- Clinical Sciences, Helsingborg
- Intensive Care Epidemiology (research group)
- Clinical infection medicine (research group)
- SWECRIT (research group)
- Center for cardiac arrest (research group)
- publishing date
- 2024-07-23
- type
- Contribution to journal
- publication status
- epub
- subject
- in
- Journal of Intensive Care Medicine
- article number
- 8850666241255328
- publisher
- SAGE Publications
- external identifiers
-
- scopus:85199877361
- pmid:39042144
- ISSN
- 0885-0666
- DOI
- 10.1177/08850666241255328
- language
- English
- LU publication?
- yes
- id
- 6190f576-c04b-4ab1-a007-876e29ea9018
- date added to LUP
- 2024-08-03 20:13:43
- date last changed
- 2024-08-05 09:02:24
@article{6190f576-c04b-4ab1-a007-876e29ea9018, abstract = {{<p> Background: The aim of this study was to investigate the development of fatigue and mental illness between 3 and 12 months after critical COVID-19 and explore risk factors for long-lasting symptoms. Study Design and Methods: A prospective, multicenter COVID-19 study in southern Sweden, including adult patients (≥18 years) with rtPCR-confirmed COVID-19 requiring intensive care. Survivors were invited to a follow-up at 3 and 12 months, where patient-reported symptoms were assessed using the Modified Fatigue Impact Scale (MFIS), the Hospital Anxiety and Depression Scale (HADS) and the Posttraumatic Stress Disorder Checklist version 5 (PCL-5). The development between 3 and 12 months was described by changes in relation to statistical significance and suggested values for a minimally important difference (MID). Potential risk factors for long-lasting symptoms were analyzed by multivariable logistic regression. Results: At the 3-month follow-up, 262 survivors (87%) participated, 215 (72%) returned at 12 months. Fatigue was reported by 50% versus 40%, with a significant improvement at 12 months (MFIS; median 38 vs. 33, P < .001, MID ≥4). There were no significant differences in symptoms of mental illness between 3 and 12 months, with anxiety present in 33% versus 28%, depression in 30% versus 22%, and posttraumatic stress disorder in 17% versus 13%. A worse functional outcome and less sleep compared to before COVID-19 were risk factors for fatigue and mental illness at 12 months. Conclusions: Fatigue improved between 3 and 12 months but was still common. Symptoms of mental illness remained unchanged with anxiety being the most reported. A worse functional outcome and less sleep compared to before COVID-19 were identified as risk factors for reporting long-lasting symptoms. </p>}}, author = {{Hultgren, Malin and Didriksson, Ingrid and Håkansson, Anders and Andertun, Sara and Frigyesi, Attila and Mellerstedt, Erik and Nelderup, Maria and Nilsson, Anna C and Reepalu, Anton and Spångfors, Martin and Friberg, Hans and Lilja, Gisela}}, issn = {{0885-0666}}, language = {{eng}}, month = {{07}}, publisher = {{SAGE Publications}}, series = {{Journal of Intensive Care Medicine}}, title = {{Prolonged Fatigue and Mental Health Challenges in Critical COVID-19 Survivors}}, url = {{http://dx.doi.org/10.1177/08850666241255328}}, doi = {{10.1177/08850666241255328}}, year = {{2024}}, }